The BCL-2 modifying factor, BMF which is a pro-apoptotic activator, was reported to be conjointly downregulated by HDAC1 and 8; inhibition of HDAC8 by methylselenopyruvate in colon cancer cells restored BMF downregulation and thereby activated apoptosis [150,179]. Here, BMF is linked to malignant colon neoplasm.